Delivery Order SPE2DB22D2007-SPE2DB25FJ5KM
- Not listed
- The Defense Logistics Agency awarded a $12,029.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a continuation of the company's pharmaceutical supply services to the federal government. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $24,059.26, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $36,088.89, represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The order is scheduled for completion by October 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-unit packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed price contract valued at $13,251.75, with completion targeted for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,254.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 25 mg tablets (30-count unit of use packaging). The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global...
- The Defense Logistics Agency awarded a $12,029.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Promacta 75 mg tablets (30-unit packages). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support program for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units, with a ceiling value of $8,026.53 and a firm fixed price structure. This award represents a non-set-aside competitive procurement that will be performed at the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $36,088.89 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitive, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of October 20, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate office. As a major pharmaceutical...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5KMDelivery Order
The Defense Logistics Agency awarded a $72,177.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is scheduled for completion by October 20, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and other federal healthcare systems. Promacta is an immunosuppressant medication used to treat certain blood disorders, reflecting AmerisourceBergen's extensive role in supplying specialty pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. As one of the nation's major pharmaceutical distributors, AmerisourceBergen maintains a significant federal procurement presence through its DLA contracts, which encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This award demonstrates the company's continued capability to fulfill federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $72.2k | 9/26/25 |